ABSTRACT
Introduction Differentiated service delivery (DSD) models have been widely implemented for patients who are established in HIV care. However, DSD has rarely been offered to those newly diagnosed with HIV. We conducted a study to assess the effectiveness of early fast-track care during the COVID-19 pandemic and a period of severe civil unrest at GHESKIO, in Haiti.
Methods We conducted a pilot randomized trial among adults presenting with World Health Organization Stage 1 or 2 disease at HIV diagnosis to determine whether early fast-track care (at eight to 12 weeks after same-day HIV testing and ART initiation) was associated with superior outcomes, compared with standard care (deferred eligibility for fast-track care). All participants received tenofovir disoproxil fumarate/lamivudine/dolutegravir (TLD), and HIV-1 RNA <200 copies/mL was required prior to initiating fast-track care. The primary outcome was 48-week HIV-1 RNA <200 copies/mL, with intention-to-treat analysis.
Results From December 13, 2020, to August 19, 2022, 247 participants were randomized; 2 met protocol-specified criteria for late exclusions, leaving a study population of 245 (standard: 116; early fast-track: 129). All participants initiated TLD on the day of HIV diagnosis. In the standard group, 2 (1.7%) died, 106 (91.4%) were retained in care, and 78 (67.2%) received 48-week viral load testing; 66 (84.6% of those tested; 56.9% of those randomized) had HIV-1 RNA <200 copies/mL. In the early fast-track group, 1 (0.8%) died, 112 (86.8%) were retained in care, and 87 (67.4%) received 48-week viral load testing; 79 (90.8% of those tested; 61.2% of those randomized) had 48-week HIV-1 RNA <200 copies/mL. There was no difference in primary outcome (48-week HIV-1 RNA <200 copies/mL) between the early fast-track and standard groups (61.2% vs. 56.9%; RD: 0.043; 95% CI: -0.080, 0.167).
Conclusions The provision of fast-track care as early as 8 weeks after TLD initiation is associated with high levels of retention in care and viral suppression in a setting of severe civil unrest, with no difference in outcome compared to deferred eligibility for fast-track care. Completion of 48-week viral load testing was suboptimal; low-cost point-of-care testing capacity may facilitate completion of viral load testing in this setting.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04311944
Funding Statement
This study was funded by a grant from ViiV Healthcare.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the institutional review boards at the Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Brigham and Women's Hospital, and Weill Cornell Medical College. Written informed consent was obtained from all participants.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
